Condition: Pancreas Disease · Liver Diseases · Surgical Procedure, Unspecified · Sponsor: Fundacion Miguel Servet
The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
This description comes directly from the study's public registry record.
Francisco Javier Herrera Cabezón, MD · 0034 848422187 · javier.herrera.cabezon@cfnavarra.es
Pablo Sánchez Acedo, MD · 0034 848422187 · pablosanchez_84@hotmail.com
Always discuss trial participation with your own doctor first.
| Complejo Hospitalario de Navarra | Pamplona, Navarre, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04556019